Skip to main content
logo
MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
4.255
-0.085 (-1.96%)
Aug 10, 2026, 1:37 PM EDT - Market open

MiMedx Group Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
355.17418.63348.88321.48267.84242.02
Revenue Growth
-2.36%19.99%8.52%20.03%10.67%-2.50%
Gross Profit
280.05345.62288.81266.84219.53202.39
Operating Income
8.7563.8958.8737.12-14.73-7.05
Net Income
6.2448.5842.4258.23-30.2-10.29
Earnings Per Share
0.040.320.280.37-0.33-0.17
EPS Growth
-80.95%14.29%-24.32%---

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
135.84166.12104.428265.9587.08
Total Debt
17.2117.9718.8349.148.5948.13
Net Cash (Debt)
118.63148.1585.5932.917.3638.96
Net Cash Growth
18.15%73.11%160.13%89.57%-55.45%-19.04%
Net Cash Per Share
0.800.990.570.230.150.35

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
46.157466.226.78-17.89-1.98
Capital Expenditures
-1.65-1.03-1.68-1.99-1.51-3.22
Free Cash Flow
44.572.9764.5224.79-19.41-5.2
Free Cash Flow Growth
-22.11%13.11%160.27%---

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
78.85%82.56%82.78%83.01%81.96%83.63%
Operating Margin
2.46%15.26%16.87%11.55%-5.50%-2.91%
Pretax Margin
3.25%15.83%16.42%9.53%-7.37%-4.98%
Profit Margin
1.76%11.60%12.16%18.11%-11.27%-4.25%
FCF Margin
12.53%17.43%18.49%7.71%-7.25%-2.15%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
100.1721.1634.3623.70--
Forward PE
422.0021.6132.8935.0812.6712.67
P/FCF Ratio
14.2113.7421.9151.74--
PS Ratio
1.782.394.053.991.182.79